Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par promoteur : Swiss Group for Clinical Cancer Research SAKK
Femme et Homme Max 99 ans
Swiss Group for Clinical Cancer Research SAKK
MAJ Il y a 4 ans
Protocol SAKK 77/06 and SASL 23 Continuous sunitinib treatment in patients with unresectable hepatocellular carcinoma A multicenter phase II trial
To demonstrate antitumor activity of continuous sunitinib (Sutent®) treatment in patients with unresectable hepatocellular carcinoma.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Swiss Group for Clinical Cancer Research SAKK
MAJ Il y a 4 ans
Rituximab with or without Ibrutinib for untreated patients with advanced follicular lymphoma in need of therapy
The objective of this trial is to study the activity and the safety of the 1st line treatment with Ibrutinib in combination with Rituximab for patients with advanced follicular lymphoma in need of the...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Homme Max 99 ans
Swiss Group for Clinical Cancer Research SAKK
MAJ Il y a 4 ans
Carboplatin chemotherapy and involved node radiotherapy in stage IIA/B seminoma
The main objective of this trial is to test the efficacy and safety of carboplatin chemotherapy and involved node radiotherapy in patients with stage IIA/B seminoma.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations